Kader, Y. A., Le Chevalier, T., El-Nahas, T., & Sakr, A. (2013). Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel and cisplatin/pemetrexed in chemotherapy-naïve patients with advanced non-squamous bronchogenic carcinoma not harboring EGFR mutation. Dove Medical Press.

Kader, Yasser Abdel, Thierry Le Chevalier, Tamer El-Nahas, und Amr Sakr. Comparative Study Analyzing Survival and Safety of Bevacizumab/carboplatin/paclitaxel and Cisplatin/pemetrexed in Chemotherapy-naïve Patients With Advanced Non-squamous Bronchogenic Carcinoma Not Harboring EGFR Mutation. Dove Medical Press, 2013.

Kader, Yasser Abdel, Thierry Le Chevalier, Tamer El-Nahas, und Amr Sakr. Comparative Study Analyzing Survival and Safety of Bevacizumab/carboplatin/paclitaxel and Cisplatin/pemetrexed in Chemotherapy-naïve Patients With Advanced Non-squamous Bronchogenic Carcinoma Not Harboring EGFR Mutation. Dove Medical Press, 2013.